UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Response to a Monovalent 2009 Influenza A (H1N1) Vaccine

The New England journal of medicine, 2009-12, Vol.361 (25), p.2405-2413

2009

Volltextzugriff (PDF)

Phase I and Pharmacokinetic Study of Photodynamic Therapy for High-Grade Gliomas Using a Novel Boronated Porphyrin

Journal of clinical oncology, 2001-01, Vol.19 (2), p.519-524

2001

Volltextzugriff (PDF)

High-Dose Chemotherapy With Autologous Stem-Cell Support As Adjuvant Therapy in Breast Cancer: Overview of 15 Randomized Trials

Journal of clinical oncology, 2011-08, Vol.29 (24), p.3214-3223

2011

Volltextzugriff (PDF)

Safety and immunogenicity of a prototype adjuvanted inactivated split-virus influenza A (H5N1) vaccine in infants and children

Vaccine, 2008-11, Vol.26 (50), p.6383-6391

2008

Volltextzugriff (PDF)

Development of pancytopenia with neutralizing antibodies to thrombopoietin after multicycle chemotherapy supported by megakaryocyte growth and development factor

Blood, 2002-04, Vol.99 (7), p.2599-2602

2002

Volltextzugriff (PDF)

Phase I and II randomised trials of the safety and immunogenicity of a prototype adjuvanted inactivated split-virus influenza A (H5N1) vaccine in healthy adults

Vaccine, 2008-08, Vol.26 (33), p.4160-4167

2008

Volltextzugriff (PDF)

Efficacy of a trivalent influenza vaccine against seasonal strains and against 2009 pandemic H1N1: A randomized, placebo-controlled trial

Vaccine, 2016-09, Vol.34 (41), p.4991-4997

2016

Volltextzugriff (PDF)

Phase 1 study of HPV16-specific immunotherapy with E6E7 fusion protein and ISCOMATRIX™ adjuvant in women with cervical intraepithelial neoplasia

Vaccine, 2004-11, Vol.23 (2), p.172-181

2004

Volltextzugriff (PDF)

A Phase I Study of Recombinant Human Leukemia Inhibitory Factor in Patients with Advanced Cancer

Clinical cancer research, 2003-06, Vol.9 (6), p.2056-2065

2003

Volltextzugriff (PDF)

Thrombopoietic effects of pegylated recombinant human megakaryocyte growth and development factor (PEG-rHuMGDF) in patients with advanced cancer

The Lancet (British edition), 1996-11, Vol.348 (9037), p.1279-1281

1996

Volltextzugriff (PDF)

Multicycle Dose-Intensive Chemotherapy for Women With High-Risk Primary Breast Cancer: Results of International Breast Cancer Study Group Trial 15-95

Journal of clinical oncology, 2006-01, Vol.24 (3), p.370-378

2006

Volltextzugriff (PDF)

Safety and immunogenicity of an inactivated thimerosal‐free influenza vaccine in infants and children

Influenza and other respiratory viruses, 2009-11, Vol.3 (6), p.315-325

2009

Volltextzugriff (PDF)

Failing to live up to the fanfare? A personal perspective on obstacles to the clinical development of thrombopoietic agents

International journal of hematology, 2001-12, Vol.74 (4), p.390-396

2001

Volltextzugriff (PDF)

Enhancement of Platelet Recovery After Myelosuppressive Chemotherapy by Recombinant Human Megakaryocyte Growth and Development Factor in Patients With Advanced Cancer

Journal of clinical oncology, 2000-08, Vol.18 (15), p.2852-2861

2000

Volltextzugriff (PDF)

Biologic and structural differences of thrombopoietic growth factors

Seminars in hematology, 2000-04, Vol.37 (2 Suppl 4), p.19-27

2000

Volltextzugriff (PDF)

Multicycle High-Dose Chemotherapy and Filgrastim-Mobilized Peripheral-Blood Progenitor Cells in Women With High-Risk Stage II or III Breast Cancer: Five-Year Follow-Up

Journal of clinical oncology, 1999-01, Vol.17 (1), p.82-92

1999

Volltextzugriff (PDF)

KRN8602 (MX2-Hydrochloride): An Active New Agent for the Treatment of Recurrent High-Grade Glioma

Journal of clinical oncology, 1999-08, Vol.17 (8), p.2579-2584

1999

Volltextzugriff (PDF)

Megakaryocyte Growth and Development Factor: A Review of Early Clinical Studies

The oncologist (Dayton, Ohio), 1997-10, Vol.2 (5), p.311-318

1997

Volltextzugriff (PDF)

Thrombopoietin

Cancer investigation, 2001, Vol.19 (6), p.660-666

2001

Volltextzugriff (PDF)

Randomized, blinded, placebo-controlled phase I trial of pegylated recombinant human megakaryocyte growth and development factor with filgrastim after dose-intensive chemotherapy in patients with advanced cancer

Blood, 1997-05, Vol.89 (9), p.3118-3128

1997

Volltextzugriff (PDF)

Recent advances in carcinoids and gastrointestinal neuroendocrine tumors

Current opinion in oncology, 1991-02, Vol.3 (1), p.109-120

1991

Volltextzugriff (PDF)

Cardiac effects of high-dose epirubicin and cyclophosphamide in women with poor prognosis breast cancer

Annals of oncology, 1999-01, Vol.10 (1), p.53-58

1999

Volltextzugriff (PDF)

Biologic and structural differences of thrombopoietic growth factors

Seminars in hematology, 2000-04, Vol.37 (2, Suppl 4), p.19-27, Article ashem0370019

2000

Volltextzugriff (PDF)

Early australian clinical studies with pegylated recombinant human megakaryocyte growth and development factor

Stem cells (Dayton, Ohio), 1998, Vol.16 (S1), p.225-229

Basser, Russell L.

1998

Volltextzugriff (PDF)

Strategies for prevention of anthracycline cardiotoxicity

Cancer treatment reviews, 1993, Vol.19 (1), p.57-77

1993

Volltextzugriff (PDF)

1 – 25 von 39

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(38)
Mit Volltextzugriff
(38)

Publikationsform

Artikel
(39)

Sprache

Englisch
(39)
Japanisch
(2)

Erscheinungsjahr

n.n

Thema

Humans
(36)
Life Sciences & Biomedicine
(34)
Science & Technology
(34)
Biological And Medical Sciences
(28)
Female
(27)
Medical Sciences
(25)
Middle Aged
(23)
Adult
(21)
Oncology
(19)
Pharmacology. Drug Treatments
(19)
Male
(16)
Antineoplastic Agents
(13)
Aged
(12)
Chemotherapy
(12)
Cyclophosphamide - Administration & Dosage
(11)
Neoplasms - Drug Therapy
(10)
Filgrastim
(9)
Antineoplastic Combined Chemotherapy Protocols - Adverse Effects
(8)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(8)
Dose-Response Relationship, Drug
(8)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Response to a Monovalent 2009 Influenza A (H1N1) Vaccine

Phase I and Pharmacokinetic Study of Photodynamic Therapy for High-Grade Gliomas Using a Novel Boronated Porphyrin

High-Dose Chemotherapy With Autologous Stem-Cell Support As Adjuvant Therapy in Breast Cancer: Overview of 15 Randomized Trials

Safety and immunogenicity of a prototype adjuvanted inactivated split-virus influenza A (H5N1) vaccine in infants and children

Development of pancytopenia with neutralizing antibodies to thrombopoietin after multicycle chemotherapy supported by megakaryocyte growth and development factor

Phase I and II randomised trials of the safety and immunogenicity of a prototype adjuvanted inactivated split-virus influenza A (H5N1) vaccine in healthy adults

Efficacy of a trivalent influenza vaccine against seasonal strains and against 2009 pandemic H1N1: A randomized, placebo-controlled trial

Phase 1 study of HPV16-specific immunotherapy with E6E7 fusion protein and ISCOMATRIX™ adjuvant in women with cervical intraepithelial neoplasia

A Phase I Study of Recombinant Human Leukemia Inhibitory Factor in Patients with Advanced Cancer

Thrombopoietic effects of pegylated recombinant human megakaryocyte growth and development factor (PEG-rHuMGDF) in patients with advanced cancer

Multicycle Dose-Intensive Chemotherapy for Women With High-Risk Primary Breast Cancer: Results of International Breast Cancer Study Group Trial 15-95

Safety and immunogenicity of an inactivated thimerosal‐free influenza vaccine in infants and children

Failing to live up to the fanfare? A personal perspective on obstacles to the clinical development of thrombopoietic agents

Enhancement of Platelet Recovery After Myelosuppressive Chemotherapy by Recombinant Human Megakaryocyte Growth and Development Factor in Patients With Advanced Cancer

Biologic and structural differences of thrombopoietic growth factors

Multicycle High-Dose Chemotherapy and Filgrastim-Mobilized Peripheral-Blood Progenitor Cells in Women With High-Risk Stage II or III Breast Cancer: Five-Year Follow-Up

KRN8602 (MX2-Hydrochloride): An Active New Agent for the Treatment of Recurrent High-Grade Glioma

Megakaryocyte Growth and Development Factor: A Review of Early Clinical Studies

Thrombopoietin

Randomized, blinded, placebo-controlled phase I trial of pegylated recombinant human megakaryocyte growth and development factor with filgrastim after dose-intensive chemotherapy in patients with advanced cancer

Recent advances in carcinoids and gastrointestinal neuroendocrine tumors

Cardiac effects of high-dose epirubicin and cyclophosphamide in women with poor prognosis breast cancer

Biologic and structural differences of thrombopoietic growth factors

Early australian clinical studies with pegylated recombinant human megakaryocyte growth and development factor

Strategies for prevention of anthracycline cardiotoxicity

Suchergebnisse filtern